Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06330714 · ClinicalTrials.gov registry record
Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements
A clinical trial of Chronic Disease of Cardiovascular System, sponsored by Aventyn.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT06330714 is a study of Chronic Disease of Cardiovascular System that has completed, run by Aventyn. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06330714, a study of Chronic Disease of Cardiovascular System, has completed, sponsored by Aventyn.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is planned as a feasibility study. The primary objective is to evaluate a specially designed patient monitoring software Vitalbeat and standard mobile device hub termed Intel Health Application Platform (IHAP) in terms of its reliability, seamless data transmission and early data availability to the physician to improve patient physician interaction. The second objective is assessing patient response to use of mobile device monitoring and patient self-monitoring skills to transmit vital signs data using the IHAP wireless home hub device
Conditions Studied
Interventions
- OTHER Symptoms of chronic illness.
Study Locations (1)
Arizona
- Institute for Liver Health - Chandler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2018-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06330714
The ClinicalTrials.gov registry entry for NCT06330714 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aventyn, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Disease of Cardiovascular System appearing as the primary indexed condition, and to 1 intervention - of which Symptoms of chronic illness. is the first listed.
NCT06330714 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT06330714 about?
NCT06330714 is a clinical study titled "Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements". This is planned as a feasibility study. The primary objective is to evaluate a specially designed patient monitoring software Vitalbeat and standard mobile device hub termed Intel Health Application Platform (IHAP) in terms of its reliability, seamless data transmission and early data availability ...
What is the current status of trial NCT06330714?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2018-07-01. Estimated completion is 2018-12-30.
What conditions does trial NCT06330714 study?
This clinical trial studies the following conditions: Chronic Disease of Cardiovascular System.
What interventions are being tested in trial NCT06330714?
The interventions under investigation include: Symptoms of chronic illness. (OTHER).
Who is sponsoring clinical trial NCT06330714?
This trial is sponsored by Aventyn, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06330714 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.